Skip to content

Moringa Oleifera and Nutriton oh HIV patients

IMPACT OF MORINGA OLEIFERA SUPPLEMENTATION ON BODY MASS INDEX AND IMMUNE RESPONSE OF HIV-PATIENTS UNDER ANTIRETROVIRAL THERAPY A SINGLE BLIND RANDOMIZED CLINICAL TRIAL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201505001076143
Enrollment
Unknown
Registered
2015-03-17
Start date
2013-03-15
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS

Interventions

Moringa oleifera powder
counseling nutritonal

Sponsors

Public Health School, Université Libre de Brussels
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: the patients included in the study had 18 years old above, treated with ART, at clinical stages 2 and 3 or 4 according to WHO classification but stabilied (without opportunisctic affection upon inclusion in the study). Without renal dysfunction, without adverse symptoms of malabsorption (digestive i.d without diarrhea in the three weeks preceding the beginning of study), and with a stable weight curve tree going months preceding the intervention study.

Exclusion criteria

Exclusion criteria: were excluded from study pregnant women patients and patient who were in stages 1,2 ,3 and 4 but not stabilized, as welle as those who did attend not consent, or who did not attend the consultation. In addition to those with renal dysfunction.

Design outcomes

Primary

MeasureTime frame
were changes in body mass index and biological parameters;Changes in biological parameters

Secondary

MeasureTime frame
Changes in BMI according to chacteristiques of patients

Countries

Democratic Republic of the Congo

Contacts

Public ContactMboma Bibi
bimbo_tshi@yahoo.fr0024385044288

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026